Three Movers to Watch for: QUALCOMM Incorporated (QCOM), Illumina, Inc. (ILMN), Hanesbrands Inc. (HBI)

QUALCOMM Incorporated (QCOM) retreated with the stock falling -0.03% or $-0.02 to close at $65.63 on light trading volume of 6.07M compared its three months average trading volume of 8.86M. The San Diego California 92121 based company operating under the Communication Equipment industry has been trending up for the last 52 weeks, with the shares price now 47.55% up for the period and up by 0.66% so far this year. With price target of $73.5 and a 60.93% rebound from 52-week low, QUALCOMM Incorporated has plenty of upside potential, making it a hold with a view buy.

QUALCOMM Incorporated develops, designs, manufactures, and markets digital communications products and services in China, South Korea, Taiwan, the United States, and internationally. The company operates through three segments: Qualcomm CDMA Technologies (QCT); Qualcomm Technology Licensing (QTL); and Qualcomm Strategic Initiatives (QSI). The QCT segment develops and supplies integrated circuits and system software based on code division multiple access (CDMA), orthogonal frequency division multiple access (OFDMA), and other technologies for use in voice and data communications, networking, application processing, multimedia, and global positioning system products. The QTL segment grants licenses or provides rights to use portions of its intellectual property portfolio, which include various patent rights useful in the manufacture and sale of certain wireless products comprising products implementing CDMA2000, WCDMA, CDMA TDD, and/or LTE standards, as well as their derivatives. The QSI segment invests in early-stage companies in various industries, including digital media, e-commerce, healthcare, and wearable devices for supporting the design and introduction of new products and services for voice and data communications. The company also develops and offers products for implementation of small cells; mobile health products and services; software products, and content and push-to-talk enablement services to wireless operators; and development, and other services and related products to the United States government agencies and their contractors. In addition, it licenses chipset technology and products for data centers. QUALCOMM Incorporated was founded in 1985 and is headquartered in San Diego, California.

Illumina, Inc. (ILMN) gained $23.5 to close the day at a new closing price of $165.04, a 16.6% increase in value from its previous closing price that moved the stock 38.26% above its 52 week low of $119.37. A total of 6.03M shares exchanged hands during the day compared with its three month average trading volume of 1.6M. The stock, currently situated -11.69% below its 52 week high. The stock is up by 33.66% in the past one month and down by -10.72% over the past three months. With a one year target estimate of $140.41 and RSI of 84.4, the stock still has upside potential, making it a sell for now.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Hanesbrands Inc. (HBI) shares were up in last trading by 0.95% to $22.43. It experienced lighter than average volume on day. The stock increased in value by almost 1.4% over the past week and fell -2.01% in the past month. It is currently trading -3.93% below its 50 day moving average and -12.51% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -27.25% decrease in value from its one year high of $31.36. The RSI indicator value of 49.27, lead us to believe that it is a hold for now.

Hanesbrands Inc., a consumer goods company, designs, manufactures, sources, and sells various basic apparels for men, women, and children in the United States. The company operates through four segments: Innerwear, Activewear, Direct to Consumer, and International. It sells bras, panties, shapewears, hosiery, men’s underwear, children’s underwear, and socks; and other activewear, such as T-shirts, fleece, sport shirts, performance T-shirts and shorts, sports bras, and thermals, as well as licensed logo apparel in collegiate bookstores and other channels. The company licenses its Champion name for footwear and sports accessories. It provides its products primarily under the Maidenform, Bali, Playtex, Hanes, JMS/Just My Size, Lilyette, Wonderbra, Donna Karan, DKNY, Champion, Polo Ralph Lauren, L’eggs, Hanes Beefy-T, Gear for Sports, Duofold, DIM, Nur Die/Nur Der, Lovable, Shock Absorber, Abanderado, Zorba, Rinbros, Kendall, Sol y Oro, Fila, Bellinda, Edoo, and Track N Field brand names. The company markets its products through retailers, wholesalers, and third party embellishers, as well as directly to consumers. As of January 2, 2016, it operated 252 outlet stores in the United States; and Websites under the Hanes, One Hanes Place, JMS/Just My Size, Champion, and Maidenform names. The company also sells its products in Europe, Asia, Latin America, Canada, Australia, the Middle East, Africa, and the Caribbean. Hanesbrands Inc. was founded in 2005 and is headquartered in Winston-Salem, North Carolina.

 

Trader’s Round Up: Sprouts Farmers Market, Inc. (SFM), Illumina, Inc. (ILMN), Public Service Enterprise Group Incorporated (PEG)

Sprouts Farmers Market, Inc. (SFM) retreated with the stock falling -0.2% or $-0.04 to close at $19.51 on light trading volume of 2.33M compared its three months average trading volume of 2.54M. The Phoenix Arizona 85054 based company operating under the Grocery Stores industry has been trending down for the last 52 weeks, with the shares price now -24.38% down for the period and up by 3.12% so far this year. With price target of $24.13 and a 4.33% rebound from 52-week low, Sprouts Farmers Market, Inc. has plenty of upside potential, making it a hold with a view buy.

Sprouts Farmers Market, Inc., together with its subsidiaries, operates as a retailer of fresh, natural, and organic food in the United States. The company’s retail stores offer fresh produce, bulk foods, vitamins and supplements, grocery, meat and seafood, deli, bakery, dairy, frozen foods, body care and natural household items, beer and wine, and dairy alternatives. As of November 3, 2016, it operated 252 stores in 13 states. Sprouts Farmers Market, Inc. was founded in 2002 and is headquartered in Phoenix, Arizona.

Illumina, Inc. (ILMN) gained $6.93 to close the day at a new closing price of $141.49, a 5.15% increase in value from its previous closing price that moved the stock 18.53% above its 52 week low of $119.37. A total of 2.33M shares exchanged hands during the day compared with its three month average trading volume of 1.57M. The stock, which fluctuated between $137.4 and $141.88 during the day, currently situated -24.29% below its 52 week high. The stock is up by 11.94% in the past one month and down by -23.49% over the past three months. With a one year target estimate of $141.65 and RSI of 68.73, the stock still has upside potential, making it a hold for now.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Public Service Enterprise Group Incorporated (PEG) shares were up in last trading by 1.01% to $44.2. It experienced lighter than average volume on day. The stock increased in value by almost 0.34% over the past week and grew 7.88% in the past month. It is currently trading 5.77% above its 50 day moving average and 2.65% above its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -4.07% decrease in value from its one year high of $47.41. The RSI indicator value of 60.93, lead us to believe that it is a hold for now.

Public Service Enterprise Group Incorporated, through its subsidiaries, operates as an energy company primarily in the Northeastern and Mid- Atlantic United States. The company operates nuclear, coal, gas, oil-fired, and renewable generation facilities with a generation capacity of approximately 11,678 megawatts. It sells electricity, natural gas, emissions credits, and a series of energy-related products. The company also transmits electricity; and distributes electricity and gas to residential, commercial, and industrial customers, as well as invests in solar generation projects, and implements energy efficiency and demand response programs. In addition, it offers appliance services and repairs to customers. As of December 31, 2015, the company’s electric transmission and distribution system included 24,022 circuit miles, of which 8,226 circuit miles were underground; and 848,496 poles, of which 549,636 poles were jointly-owned, as well as 4 electric distribution headquarters and 5 sub-headquarters. It also owned and operated 18,112 miles of gas mains; owned 12 gas distribution headquarters and 2 sub-headquarters; owned 1 meter shop; operated 60 natural gas metering and regulating stations; and owned 43 switching stations with an aggregate installed capacity of 29,090 megavolt-amperes (MVA) and 246 substations with an aggregate installed capacity of 8,179 MVA. Public Service Enterprise Group Incorporated was founded in 1985 and is headquartered in Newark, New Jersey.

 

Momentum Stocks: Illumina Inc. (ILMN), General Dynamics Corporation (GD)

Illumina Inc. (ILMN) grew with the stock adding 1.82% or $0.24 to close at $134.63 on active trading volume of 1.42M compared its three months average trading volume of 1.3M. The San Diego California 92122 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -12.04% down for the period and down by -28.59% so far this year. With price target of $144.44 and a 7.85% rebound from 52-week low, Illumina Inc. has plenty of upside potential, making it a hold with a view buy.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

General Dynamics Corporation (GD) had a active trading with around 1.42M shares changing hands compared to its three month average trading volume of 1.25M. The stock traded between $150.9 and $152.43 before closing at the price of $152.39 with 1.72% change on the day. The Falls Church Virginia 22042 based company is currently trading 27.39% above its 52 week low of $121.61 and -2.43% below its 52 week high of $156.97. Both the RSI indicator and target price of  and $172.94 respectively, lead us to believe that it could rise over the coming weeks.

General Dynamics Corporation operates as an aerospace and defense company worldwide. It operates through four business groups: Aerospace; Combat Systems; Information Systems and Technology; and Marine Systems. The Aerospace group designs, develops, manufactures, and outfits business-jet aircraft; provides aircraft services, such as maintenance, repair, aircraft management, charter, fixed-base operational, and staffing services; and performs aircraft completion services for other original equipment manufacturers. The Combat Systems group is involved in the design, development, production, modernization, and sustainment of combat vehicles, weapons systems, and munitions. This group offers wheeled combat and tactical vehicles; main battle tanks and tracked combat vehicles; armaments; and maintenance and logistics support and sustainment services. The Information Systems and Technology group provides technologies, products, and services that support a range of military, federal/civilian, state, local, and commercial customers. This group offers information technology solutions and mission support services; communication, command-and-control, and computer mission systems; and imagery, signals, and multi-intelligence systems for customers in the defense sector, intelligence and homeland security communities, and the United States allies. The Marine Systems group designs, constructs, and repairs surface ships and submarines for the United States Navy and Jones Act ships for commercial customers. This group offers nuclear-powered surface combatants, auxiliary and combat-logistics ships, and commercial product carriers and containerships; and provides design and engineering support services, as well as overhaul, repair, and lifecycle support services. The company was founded in 1899 and is based in Falls Church, Virginia.

 

Traders Recap: Duke Energy Corporation (DUK), Plains All American Pipeline, L.P. (PAA), Illumina Inc. (ILMN)

Duke Energy Corporation (DUK) failed to extend gains with the stock declining -0.51% or $-0.4 to close the day at $78.02 on lower than average trading volume of 2.13M shares, compared to its three month average trading volume of 2.96M. The Charlotte North Carolina 28202 based company has been underperforming the electric utilities companies by -9.007% for last three months and its recent losses have trimmed gains to 12.74% YTD, versus the electric utilities industry which is up 12.7% for the same period. The RSI of 45.43 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

Duke Energy Corporation, together with its subsidiaries, operates as an energy company in the United States and Latin America. It operates through three segments: Regulated Utilities, International Energy, and Commercial Portfolio. The Regulated Utilities segment generates, transmits, distributes, and sells electricity in the Carolinas, Florida, Ohio, Kentucky, and Indiana; and transports and sells natural gas in southwestern Ohio and northern Kentucky. This segment owns approximately 50,000 megawatts (MW) of generation capacity; and uses coal, hydroelectric, natural gas, oil, and nuclear fuel to generate electricity. It serves approximately 7.4 million retail electric customers in 6 states in the Southeast and Midwest regions of the United States with a service area covering approximately 95,000 square miles; and approximately 525,000 retail natural gas customers in southwestern Ohio and northern Kentucky. This segment is also involved in the wholesale of electricity to incorporated municipalities, electric cooperative utilities, and other load-serving entities. The International Energy segment operates and manages power generation facilities; and markets and sells electric power, natural gas, and natural gas liquids. This segment serves retail distributors, electric utilities, independent power producers, marketers, and industrial and commercial companies. The Commercial Portfolio segment acquires, builds, develops, and operates wind and solar renewable generation and energy transmission projects. Its portfolio includes nonregulated renewable energy, electric transmission, natural gas infrastructure, and energy storage businesses. This segment has 22 wind farms and 38 commercial solar farms with a capacity of 2,400 MW across 11 states. The company was formerly known as Duke Energy Holding Corp. and changed its name to Duke Energy Corporation in April 2005. Duke Energy Corporation was incorporated in 2005 and is headquartered in Charlotte, North Carolina.

Plains All American Pipeline, L.P. (PAA) had a light trading with around 2.12M shares changing hands compared to its three month average trading volume of 2.23M. The stock traded between $32.3 and $32.71 before closing at the price of $32.45 with -0.58% change on the day. The Houston Texas 77002 based company is currently trading 131.11% above its 52 week low of $14.82 and -1.67% below its 52 week high of $33. Both the RSI indicator and target price of 63.97 and $31.93 respectively, lead us to believe that it should be put on hold over the coming weeks.

Plains All American Pipeline, L.P., through with its subsidiaries, engages in the transportation, storage, terminalling, and marketing of crude oil, natural gas liquids (NGL), natural gas, and refined products in the United States and Canada. Its Transportation segment transports crude oil and NGL through pipelines, gathering systems, trucks, and barges. As of December 31, 2015, this segment owned and leased 18,100 miles of active crude oil and NGL pipelines and gathering systems; 30 million barrels of active and above-ground tank capacity; 830 trailers; 142 transport and storage barges; and 64 transport tugs. The company’s Facilities segment provides storage, terminalling, and throughput services for crude oil, refined products, NGL, and natural gas; and NGL fractionation and isomerization, and natural gas and condensate processing services. As of December 31, 2015, it owned and operated approximately 80 million barrels of crude oil and refined products storage capacity; 25 million barrels of NGL storage capacity; 97 billion cubic feet of natural gas storage working capacity; 31 billion cubic feet of base gas; 10 natural gas processing plants; 1 condensate processing facility; 7 fractionation plants; 28 crude oil and NGL rail terminals; 6 marine facilities; and 1,100 miles of active pipelines. Its Supply and Logistics segment purchases crude oil at the wellhead, pipeline, terminal, and rail facilities; purchases cargos at load port and various locations in transit; stores inventory, and NGL and natural gas; purchases NGL; resells or exchanges crude oil and NGL; transports crude oil and NGL on trucks, barges, railcars, pipelines, and ocean-going vessels; and purchases and sells natural gas. As of December 31, 2015, it owned 13 million barrels of crude oil and NGL linefill; 5 million barrels of crude oil and NGL linefill; 990 trucks and 1,100 trailers; and 10,100 crude oil and NGL railcars. The company was founded in 1998 and is headquartered in Houston, Texas.

Illumina Inc. (ILMN) opening the day at $142. The company has seen its stock decrease in value by -26.13% so far this year. The stock was down close to -0.72% on active volume in last trading session and closed at $141.8 per share. After the recent fall, the stock is currently holding -27.83% below its 52 week high of $196.47 and 11.57% above its 12-month low of $127.1. The shares are down by over -5.87% in the last three months, and the RSI indicator value of 31.12 is neither bullish nor bearish, tempting investors to stay on the sidelines.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

 

Stocks in the Spotlight: Community Health Systems, Inc. (CYH), Las Vegas Sands Corp. (LVS), Illumina Inc. (ILMN)

Community Health Systems, Inc. (CYH) had a light trading with around 2.52M shares changing hands compared to its three month average trading volume of 4.93M. The stock traded between $10.15 and $10.67 before closing at the price of $10.53 with 4.46% change on the day. The Franklin Tennessee 37067 based company is currently trading 9.01% above its 52 week low of $9.66 and -70.17% below its 52 week high of $34.96. Both the RSI indicator and target price of 48.93 and $13.57 respectively, lead us to believe that it should be put on hold over the coming weeks.

Community Health Systems, Inc., together with its subsidiaries, owns, leases, and operates general acute care hospitals in the United States. It offers general acute care, emergency room, general and specialty surgery, critical care, internal medicine, obstetrics, diagnostic, psychiatric, and rehabilitation services, as well as skilled nursing and home care services. The company also provides outpatient services at urgent care centers, occupational medicine clinics, imaging centers, cancer centers, ambulatory surgery centers, and home health and hospice agencies. In addition, it offers management and consulting services to non-affiliated general acute care hospitals. As of February 15, 2016, the company owned, leased, or operated 195 affiliated hospitals in 29 states with approximately 30,000 licensed beds. Community Health Systems, Inc. was founded in 1985 and is headquartered in Franklin, Tennessee.

Las Vegas Sands Corp. (LVS) continued its downward trend with the stock declining -0.21% or $-0.12 to close the day at $57.45 on light trading volume of 2.52M shares, compared to its three month average trading volume of 3.98M. The Las Vegas Nevada 89109 based company has been outperforming the resorts & casinos group over the past 52 weeks, with the stock gaining 27.95%, compared to the industry which has advanced 2.69% over the same period. With RSI of 53.14, the stock should still continue to rise and get closer to its one year target estimate of $54.86, making it a hold for now.

Las Vegas Sands Corp., together with its subsidiaries, develops, owns, and operates integrated resorts in Asia and the United States. It owns and operates The Venetian Macao Resort Hotel, Sands Cotai Central, the Four Seasons Hotel Macao, Cotai Strip, the Plaza Casino, and the Sands Macao in Macao, the People’s Republic of China; and iconic Marina Bay Sands in Singapore. The company also owns and operates The Venetian Resort Hotel Casino, The Palazzo Resort Hotel Casino, and Five-Diamond luxury resorts on the Las Vegas Strip; Sands Expo and Convention Center in Las Vegas, Nevada; and the Sands Casino Resort Bethlehem in Bethlehem, Pennsylvania. Its integrated resorts include accommodations, gaming, entertainment and retail, convention and exhibition facilities, celebrity chef restaurants, and other amenities. Las Vegas Sands Corp. was founded in 1988 and is based in Las Vegas, Nevada.

Illumina Inc. (ILMN) shares were up in last trading by 2.83% to $145.22. It experienced higher than average volume on day. The stock increased in value by almost 4.48% over the past week and fell -16.13% in the past month. It is currently trading -14.64% below its 50 day moving average and -7.07% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -26.09% decrease in value from its one year high of $196.47. The RSI indicator value of 32.13, lead us to believe that it is a hold for now.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

 

Stocks Roundup: Illumina Inc. (ILMN), J. C. Penney Company, Inc. (JCP), Fitbit Inc. (FIT)

Illumina Inc. (ILMN) retreated with the stock falling -24.81% or $-45.86 to close at $138.99 on active trading volume of 11.03M compared its three months average trading volume of 1.03M. The San Diego California 92122 based company operating under the Biotechnology industry has been trending down for the last 52 weeks, with the shares price now -5.19% down for the period and down by -27.59% so far this year. With price target of $155.67 and a 9.35% rebound from 52-week low, Illumina Inc. has plenty of upside potential, making it a hold with a view buy.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

  1. C. Penney Company, Inc. (JCP) had a light trading with around 11.02M shares changing hands compared to its three month average trading volume of 14.38M. The stock traded between $8.94 and $9.15 before closing at the price of $9.01 with -0.55% change on the day. The Plano Texas 75024 based company is currently trading 50.17% above its 52 week low of $6 and -24.85% below its 52 week high of $11.99. Both the RSI indicator and target price of and $12.18 respectively, lead us to believe that it could rise over the coming weeks.
  2. C. Penney Company, Inc., through its subsidiary, J. C. Penney Corporation, Inc., sells merchandise through department stores in the United States. The company sells family apparel and footwear, accessories, fine and fashion jewelry, beauty products, and home furnishings, as well as provides various services, including styling salon, optical, portrait photography, and custom decorating. As of January 30, 2016, it operated approximately 1,021 department stores in 49 states and Puerto Rico. The company also sells its products through its Website, jcpenney.com. J. C. Penney Company, Inc. was founded in 1902 and is based in Plano, Texas.

Fitbit Inc. (FIT) saw its value decrease by -2.95% as the stock dropped $-0.41 to finish the day at a closing price of $13.49. The stock was higher in trading and has fluctuated between $11.65-$41.97 per share for the past year. The shares, which traded within a range of $13.34 to $14 during the day, are down by -0.52% in the past three months and down by -20.69% over the past six months. It is currently trading -12.94% below its 20 day moving average and -10.9% below its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $21.25 a share over the next twelve months. The current relative strength index (RSI) reading is 30.9.The technical indicator lead us to believe there will be no major movement any time soon, hold.

Fitbit, Inc. provides wearable health and fitness tracking devices. It offers various products, including Fitbit Zip, an entry-level wireless tracker that allows users to track daily activity statistics, such as steps, distance, calories burned, and active minutes; Fitbit One, a clippable wireless tracker, which tracks floors climbed and sleep, as well as daily steps, distance, calories burned, and active minutes; Fitbit Flex, a wristband-style tracker that tracks steps, distance, calories burned, active minutes, and sleep; and Fitbit Charge, an activity and sleep wristband, which tracks steps, distance, calories burned, active minutes, floors climbed, and sleep. The company also provides Fitbit Alta, a customizable wristband that offers call, text, and calendar notifications when paired with the user’s phone and SmartTrack automatic exercise recognition; and Fitbit Charge HR, a wireless heart rate and activity wristband. In addition, it offers Fitbit Blaze, a smart fitness watch that provides multi-sport functionality, tracks outdoor cycling activity, and provides run cues; Fitbit Surge, a fitness watch that features a GPS watch, heart rate tracker, activity tracker, and smartwatch; Aria, a Wi-Fi connected scale that tracks weight, body fat percentage, and body mass index; and Fitbit accessories that include bands and frames for Fitbit Blaze, bands for Fitbit Alta, colored bands for Fitbit Flex, colored clips for Fitbit One and Fitbit Zip, device charging cables, wireless sync dongles, band clasps, sleep bands, and Fitbit apparel. The company offers its products through consumer electronics and specialty retailers, e-Commerce retailers, sporting goods and outdoors retailers, and wireless carriers; and corporate wellness channels, as well as directly worldwide. The company was formerly known as Healthy Metrics Research, Inc. and changed its name to Fitbit, Inc. in October 2007. Fitbit, Inc. was founded in 2007 and is headquartered in San Francisco, California.

 

Stocks Trend Analysis: Illumina Inc. (ILMN) The Hain Celestial Group, Inc. (HAIN) MeetMe, Inc. (MEET)

Illumina Inc. (ILMN) managed to rebound with the stock climbing 1.9% or $3.22 to close the day at $172.37 on active trading volume of 6.43M shares, compared to its three month average trading volume of 1.09M. The San Diego California 92122 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -16.18%, compared to the industry which has advanced 11.03% over the same period. With RSI of 67.52, the stock should still continue to rise and get closer to its one year target estimate of $154.88, making it a hold for now.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

The Hain Celestial Group, Inc. (HAIN) grew with the stock adding 1.38% or $0.52 to close at $38.31 on active trading volume of 6.4M compared its three months average trading volume of 2.12M. The Lake Success New York 11042 based company operating under the Food Wholesale industry has been trending down for the last 52 weeks, with the shares price now -40.28% down for the period and down by -5.15% so far this year. With price target of $52 and a 15.67% rebound from 52-week low, The Hain Celestial Group, Inc. has plenty of upside potential, making it a hold with a view buy.

The Hain Celestial Group, Inc. manufactures, markets, distributes, and sells organic and natural products in the United States, the United Kingdom, Canada, and Europe. Its grocery products include infant formula; infant, toddler, and kids foods; diapers and wipes; rice and grain-based products; flour and baking mixes; breads, hot and cold cereals, pasta, condiments, cooking and culinary oils, granolas, granola bars, and cereal bars; canned, chilled fresh, aseptic, and instant soups; Greek-style yogurt; chilies and packaged grains; and chocolates and nut butters, as well as plant-based beverages and frozen desserts, such as soy, rice, almond, and coconut. The company’s grocery products also comprise juices, hot-eating, chilled and frozen desserts, cookies, crackers, gluten-free frozen entrees and bars, frozen pastas and ethnic meals, frozen fruits and vegetables, cut fresh fruits, refrigerated and frozen soy protein meat-alternative products, tofu, seitan and tempeh products, jams, fruit spreads and jelly, honey, marmalade, and other food products. In addition, it provides snack products, such as potato, root vegetable, and other vegetable chips, as well as straws, tortilla chips, whole grain chips, pita chips, puffs, and popcorn; specialty teas, including herbal, green, black, wellness, rooibos, and chai tea lattes; ready-to-drink beverages comprising organic kombucha and chai tea lattes; personal care products consisting of skin, hair and oral care, deodorants, baby care items, acne treatment, body washes, and sunscreens; and poultry and protein products, such as turkey and chicken products. The company sells its products through specialty and natural food distributors, supermarkets, natural food stores, mass-market and e-commerce retailers, food service channels and club, and drug and convenience stores in approximately 70 countries worldwide. The Hain Celestial Group, Inc. was founded in 1993 and is headquartered in Lake Success, New York.

MeetMe, Inc. (MEET) failed to extend gains with the stock declining -2.44% or $-0.13 to close the day at $5.19 on higher than average trading volume of 6.4M shares, compared to its three month average trading volume of 2.69M. The New Hope Pennsylvania 18938 based company has been outperforming the internet information providers companies by 56.6916% for last three months and its recent gains have pushed the stock slightly up 44.97% YTD, versus the internet information providers industry which is up 4.39% for the same period. The RSI of 36.58 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

MeetMe, Inc. owns and operates a social network for meeting new people on the Web and on mobile platforms in the United States. The company operates MeetMe mobile applications and meetme.com, which provide users with access to a multilingual menu of resources that promote social interaction, information sharing, and other topics of interest. It also offers online marketing capabilities, which enable marketers to display their advertisements in various formats and in various locations. The company was formerly known as Quepasa Corporation and changed its name to MeetMe, Inc. in June 2012. MeetMe, Inc. was founded in 1997 and is headquartered in New Hope, Pennsylvania.

 

Eye Catching Stocks: Novavax, Inc. (NVAX), MBIA Inc. (MBI), Illumina Inc. (ILMN)

Novavax, Inc. (NVAX) failed to extend gains with the stock declining -2.18% or $-0.16 to close the day at $7.19 on light trading volume of 3.62M shares, compared to its three month average trading volume of 5.11M. The Gaithersburg Maryland 20878 based company has been underperforming the biotechnology group over the past 52 weeks, with the stock losing -40.68%, compared to the industry which has advanced 7.99% over the same period. With RSI of 49.45, the stock should still continue to rise and get closer to its one year target estimate of $14.43, making it a hold for now.

Novavax, Inc., a clinical-stage vaccine company, focuses on discovering, developing, and commercializing recombinant nanoparticle vaccines and adjuvants. The company produces its vaccines using its proprietary recombinant nanoparticle vaccine technology. Its product pipeline includes respiratory syncytial virus (RSV) vaccine candidates for elderly and maternal immunization that are in Phase III clinical trials, as well as pediatric RSV candidate, which is in Phase I clinical trial; seasonal quadrivalent influenza and pandemic H7N9 vaccines, which are in Phase II clinical trials; vaccine candidate against Ebola Virus that is Phase I clinical trial, as well as combination respiratory vaccine candidate and seasonal influenza vaccine candidate that is in pre-clinical trial; and rabies G protein vaccine candidate, which is in Phase I/II clinical trial. The company also has pre-clinical stage programs for various infectious diseases, including the Middle East respiratory syndrome coronavirus; and develops technology for the production of immune stimulating saponin-based adjuvants. Novavax, Inc. was founded in 1987 and is headquartered in Gaithersburg, Maryland.

MBIA Inc. (MBI) fell -2.18% during last trading as the stock lost $-0.18 to finish the day at $8.07 with about 1.47M shares changing hands, compared to its three month average trading volume of 1.88M. The $1.09B market cap company, which fluctuated between $8.03 and $8.32 during the day, currently situated 53.42% above its 52 week low of $5.26 and -14.96% away from its one year high of $9.49. The RSI of 60.33 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.

MBIA Inc. provides financial guarantee insurance services to public finance markets in the United States and internationally. It operates through three segments: U.S. Public Finance Insurance, International and Structured Finance Insurance, and Corporate. The company issues financial guarantees for municipal bonds, including tax-exempt and taxable indebtedness, as well as utilities, airports, health care institutions, higher educational facilities, student loan issuers, housing authorities, and other similar agencies and obligations issued by private entities. It also insures non-U.S. public finance and global structured finance, including asset-backed obligations; and sovereign-related and sub-sovereign bonds, utilities, and privately issued bonds used for the financing of projects that include utilities, toll roads, bridges, airports, public transportation facilities, and other types of infrastructure projects, as well as offers third-party reinsurance services. MBIA Inc. was founded in 1973 and is headquartered in Purchase, New York.

Illumina Inc. (ILMN) saw its value decrease by -2.19% as the stock dropped $-3.73 to finish the day at a closing price of $166.92. The stock was higher in trading and has fluctuated between $127.1-$219.36 per share for the past year. The shares, which traded within a range of $163.72 to $170.51 during the day, are up by 24.89% in the past three months and up by 7.93% over the past six months. It is currently trading 10.89% above its 20 day moving average and 15.07% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $154.88 a share over the next twelve months. The current relative strength index (RSI) reading is 70.12. The technical indicator do not lead us to believe the stock will see more gains any time soon.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Momentum Stocks: Graphic Packaging Holding Company (GPK), salesforce.com, inc. (CRM), Illumina Inc. (ILMN)

Graphic Packaging Holding Company (GPK) grew with the stock adding 0.88% or $0.12 to close at $13.8 on active trading volume of 3.57M compared its three months average trading volume of 3.48M. The Atlanta Georgia 30328 based company operating under the Packaging & Containers industry has been trending down for the last 52 weeks, with the shares price now -3.84% down for the period and up by 8.4% so far this year. With price target of $15.24 and a 29.85% rebound from 52-week low, Graphic Packaging Holding Company has plenty of upside potential, making it a hold with a view buy.

Graphic Packaging Holding Company, together with its subsidiaries, provides paper-based packaging solutions to food, beverage, and other consumer products companies. The company operates in three segments: Paperboard Mills, Americas Paperboard Packaging, and Europe Paperboard Packaging. The company offers coated unbleached kraft (CUK) and coated recycled board (CRB) to various paperboard packaging converters and brokers; and paperboard packaging folding cartons primarily to consumer packaged goods companies serving the food, beverage, and consumer product markets. It also manufactures corrugated medium and kraft paper; offers various laminated, coated, and printed packaging structures that are produced from its CUK and CRB, as well as other grades of paperboard that are purchased from third-party suppliers; designs and manufactures specialized packaging machines that package bottles and cans, and non-beverage consumer products; and installs its packaging machines at customer plants and provides support, service, and performance monitoring of the machines. The company markets its product primarily through sales offices and broker arrangements with third parties in the Americas, Europe, and the Asia Pacific. Graphic Packaging Holding Company was founded in 1992 and is headquartered in Atlanta, Georgia.

salesforce.com, inc. (CRM) had a light trading with around 3.57M shares changing hands compared to its three month average trading volume of 3.77M. The stock traded between $81.05 and $82.12 before closing at the price of $81.5 with -0.32% change on the day. The San Francisco California 94105 based company is currently trading 54.94% above its 52 week low of $52.6 and -3.53% below its 52 week high of $84.48. Both the RSI indicator and target price of  and $97.23 respectively, lead us to believe that it could rise over the coming weeks.

salesforce.com, inc. provides enterprise cloud computing solutions, with a focus on customer relationship management to various businesses and industries worldwide. It offers enterprise cloud computing applications and platform services, including Sales Cloud that enables companies to store data, monitor leads and progress, forecast opportunities, gain insights through relationship intelligence, and collaborate around sales on desktop and mobile devices. The company also provides Service Cloud that enables companies to deliver personalized customer service and support, as well as connects their service agents with customers on various devices; and Marketing Cloud, which enables companies to plan, personalize, and optimize customer interactions. In addition, it offers Community Cloud that enables companies to engage with groups of people by giving them access to information, applications, and experts; Analytics Cloud, an application, which enables companies to deploy sales, service, marketing, and custom analytics applications using various data source; Internet of Things Cloud that enables customers to process data, as well as build personalized actions and engage with customers in real time; and App Cloud, an application development platform for companies to deliver connected applications for various business needs. In addition, the company provides professional services, including consulting, deployment, training, and design and integration services to facilitate the adoption of its cloud solutions, as well as offers various education service offerings ranging from introductory online courses to advanced architecture certifications. It sells and markets services primarily through its direct sales force, as well as through consulting firms, systems integrators, and regional partners. salesforce.com, inc. was founded in 1999 and is headquartered in San Francisco, California.

Illumina Inc. (ILMN) saw its value increase by 8.09% as the stock gained $12.15 to finish the day at a closing price of $162.25. The stock was higher in trading and has fluctuated between $127.1-$220.86 per share for the past year. The shares, which traded within a range of $145.27 to $164.13 during the day, are up by 17.07% in the past three months and down by -0.1% over the past six months. It is currently trading 11.95% above its 20 day moving average and 13.54% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $153.53 a share over the next twelve months. The current relative strength index (RSI) reading is 72.67.The technical indicator do not lead us to believe the stock will see more gains any time soon.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.

Three Movers to Watch for: NRG Yield, Inc. (NYLD), Sun Communities Inc. (SUI), Illumina Inc. (ILMN)

NRG Yield, Inc. (NYLD) grew with the stock adding 2.73% or $0.44 to close at $16.54 on light trading volume of 0.79M compared its three months average trading volume of 654.87K. The Princeton New Jersey 08540 based company operating under the Electric Utilities industry has been trending down for the last 52 weeks, with the shares price now -17.75% down for the period and up by 15.76% so far this year. With price target of $18.85 and a 62.87% rebound from 52-week low, NRG Yield, Inc. has plenty of upside potential, making it a hold with a view buy.

NRG Yield, Inc., through its subsidiaries, acquires, owns, and operates contracted renewable and conventional generation, and thermal infrastructure assets in the United States. As of December 31, 2015, it had contracted renewable and conventional generation portfolio of 4,435 net megawatt (MW). The company also owns thermal infrastructure assets with an aggregate steam and chilled water capacity of 1,315 net MW thermal equivalents, and electric generation capacity of 124 net MW. Its thermal infrastructure assets provide steam, hot water and/or chilled water, and electricity to commercial businesses, universities, hospitals, and governmental units. The company was founded in 2012 and is headquartered in Princeton, New Jersey. NRG Yield, Inc. is a subsidiary of NRG Energy, Inc.

Sun Communities Inc. (SUI) gained $0.48 to close the day at a new closing price of $75.47, a 0.64% increase in value from its previous closing price that moved the stock 26.33% above its 52 week low of $61.65. A total of 0.79M shares exchanged hands during the day compared with its three month average trading volume of 574.76K. The stock, which fluctuated between $74.5 and $75.55 during the day, currently situated -3.13% below its 52 week high. The stock is up by 6.09% in the past one month and up by 10% over the past three months. With a one year target estimate of $73.5 and RSI of 58.09, the stock still has upside potential, making it a hold for now.

Sun Communities, Inc. operates as a real estate investment trust (REIT). It owns, operates, and develops manufactured housing communities in the midwestern, southern, and southeastern United States. As of April 1, 2011, it owned and operated a portfolio of 136 communities comprising approximately 47,600 developed sites. As a REIT, it would not be subject to federal tax to the extent that it distributes at least 90% of its taxable income to its shareholders. The company, through its subsidiary, Sun Home Services, Inc., also involves in marketing, selling, and leasing new and pre-owned homes. Sun Communities, Inc. was founded in 1975 and is headquartered in Southfield, Michigan.

Illumina Inc. (ILMN) shares were up in last trading by 1.01% to $148.71. It experienced lighter than average volume on day. The stock increased in value by almost 5.28% over the past week and grew 8.76% in the past month. It is currently trading 5.4% above its 50 day moving average and -4.61% below its 200 day moving average. Following the recent increase in price, the stock’s new closing price represents a -38.64% decrease in value from its one year high of $242.37. The RSI indicator value of 61.56, lead us to believe that it is a hold for now.

Illumina, Inc. provides sequencing and array-based solutions for genetic analysis. The company’s sequencing by synthesis technology provides researchers with various applications and the ability to sequence mammalian genomes. It also offers arrays for a range of deoxyribonucleic acid and RNA analysis applications, including single nucleotide polymorphism genotyping, copy number variations analysis, gene expression analysis, and methylation analysis, as well as allow for the detection of known genetic markers on a single array. In addition, the company provides various library preparation and sequencing kits to simplify workflows and accelerate analysis; and genome sequencing, genotyping, and non-invasive prenatal testing services. It serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, agrigenomics, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as through life-science distributors. It has a collaboration agreement With MolecularMD Corporation for drug-diagnostic co-development with biopharma drug programs. Illumina, Inc. was founded in 1998 and is headquartered in San Diego, California.